Kikuchi-Fujimoto Disease: A Differential for When It is Not Systemic Lupus Erythematosus

Table 3

Leukemia/lymphoma evaluation.

Items	Results
Viability %	52%
Gate B	Lymphocytes
Marker	Percentage
CD2	72
CD3	72
CD4	43
CD5	72
CD7	64
CD8	26
CD10	2
CD11c	1
CD13	0
CD19	26
CD19+CD5+	1
CD20	26
CD23	6
CD33	0
CD34	0
CD38	63
CD45	100
CD56+CD3−	1
CD64	0
CD117	0
HLA_DR	29
Kappa CD19+	14
Lamda CD19+	11
K/L ratio	1.27